First Report of Phase 1 Studies of DZD8586, a BBB Penetrant LYN/BTK Dual Inhibitor, in Patients with B-Cell Non-Hodgkin Lymphoma (B-NHL)Yuqin Song,Keshu Zhou,Hongmei Jing,Jianqiu Wu,Haiyan Yang, Yu Bai, Ke Fang, Ziyi Liu,Jun Zhu,Chan Y. CheahBlood（2023）引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
